Erschienen in:
01.07.2011 | Original Article
Use of the Gynecare Prolift® system in surgery for pelvic organ prolapse: 1-year outcome
verfasst von:
Ganesh Raj Vaiyapuri, How Chuan Han, Lih Charn Lee, Leng Aun Arthur Tseng, Heng Fok Wong
Erschienen in:
International Urogynecology Journal
|
Ausgabe 7/2011
Einloggen, um Zugang zu erhalten
Abstract
Introduction and hypothesis
This retrospective study reports the 1-year outcome in women who underwent mesh-augmented Prolift® surgery performed from 2006 to 2008. There were a total of 254 patients, with 128, 106 and 20 patients receiving total, anterior and posterior Prolift®, respectively.
Methods
Incidence of thigh pain was lower in 2008 compared to 2006 and 2007 (p < 0.0001). The percentage of patients requiring blood transfusions (p = 0.09), duration of IDC ≥7 days (p = 0.27), wound dehiscence and re-operation rate were lower in 2008 in contrast to 2006 and 2007 (p = 0.43). Only 209 patients (82.3%) were available for review at 1 year. There were two (1.0%) cases of recurrent vault prolapse.
Results
The subjective and objective cure rates at 1 year after this mesh implant surgery in 2006, 2007 and 2008 were 92.1% and 92.1%; 97.0% and 92.4% and 100% and 97%, respectively. The mesh erosion rate was remarkably lower in 2008 as compared to 2007 and 2006 (p < 0.001).
Conclusions
This synthetic mesh-augmented implant surgery is effective and safe, and surgical outcome appears related to the learning curve of the surgeon.